These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16985695)

  • 21. Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.
    Shariat SF; Casella R; Wians FH; Ashfaq R; Balko J; Sulser T; Gasser TC; Sagalowsky AI
    Eur Urol; 2004 Mar; 45(3):304-13; author reply 313. PubMed ID: 15036675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
    Hutterer GC; Karakiewicz PI; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Serretta V; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Perrotte P; Lotan Y; Marberger MJ; Shariat SF
    BJU Int; 2008 Mar; 101(5):561-5. PubMed ID: 18257856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
    Kassouf W; Traboulsi SL; Schmitz-Dräger B; Palou J; Witjes JA; van Rhijn BW; Grossman HB; Kiemeney LA; Goebell PJ; Kamat AM
    Urol Oncol; 2016 Oct; 34(10):460-8. PubMed ID: 27368880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder.
    Bhuiyan J; Akhter J; O'Kane DJ
    Clin Chim Acta; 2003 May; 331(1-2):69-77. PubMed ID: 12691866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic assays for the detection of urothelial cancer.
    Gaston KE; Grossman HB
    Methods Mol Biol; 2010; 641():303-23. PubMed ID: 20407954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
    Bian W; Xu Z
    Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.
    Abd El Gawad IA; Moussa HS; Nasr MI; El Gemae EH; Masooud AM; Ibrahim IK; El Hifnawy NM
    J Egypt Natl Canc Inst; 2005 Sep; 17(3):193-202. PubMed ID: 16799657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bladder wash cytology and flow cytometry for the diagnosis of transitional cell carcinoma of the urinary bladder.
    Romero J; Alos L; Mallofre C; Sole M; Gutierrez R; Alcover J; Carretero P
    Eur Urol; 1992; 21 Suppl 1():13-5. PubMed ID: 1425832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combinations of urine-based tumour markers in bladder cancer surveillance.
    Horstmann M; Patschan O; Hennenlotter J; Senger E; Feil G; Stenzl A
    Scand J Urol Nephrol; 2009; 43(6):461-6. PubMed ID: 19903092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive diagnostic tests for bladder cancer: a review of the literature.
    Bassi P; De Marco V; De Lisa A; Mancini M; Pinto F; Bertoloni R; Longo F
    Urol Int; 2005; 75(3):193-200. PubMed ID: 16215303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma.
    Passerotti CC; Srougi M; Bomfim AC; Martins JR; Leite KR; Dos Reis ST; Sampaio LO; Ortiz V; Dietrich CP; Nader HB
    Urol Oncol; 2011; 29(6):710-5. PubMed ID: 19962919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder.
    Mourah S; Cussenot O; Vimont V; Desgrandchamps F; Teillac P; Cochant-Priollet B; Le Duc A; Fiet J; Soliman H
    Int J Cancer; 1998 Dec; 79(6):629-33. PubMed ID: 9842973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.
    Hautmann SH; Lokeshwar VB; Schroeder GL; Civantos F; Duncan RC; Gnann R; Friedrich MG; Soloway MS
    J Urol; 2001 Jun; 165(6 Pt 1):2068-74. PubMed ID: 11371930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomerase activity in solid transitional cell carcinoma, bladder washings, and voided urine.
    Lance RS; Aldous WK; Blaser J; Thrasher JB
    Urol Oncol; 1998 Mar; 4(2):43-9. PubMed ID: 21227190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronic acid/ Hyaluronidase as biomarkers for bladder cancer: a diagnostic meta-analysis.
    Liang Z; Zhang Q; Wang C; Shi F; Cao H; Yu Y; Zhang M; Liu X
    Neoplasma; 2017; 64(6):901-908. PubMed ID: 28895415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.
    Eissa S; Kassim SK; Labib RA; El-Khouly IM; Ghaffer TM; Sadek M; Razek OA; El-Ahmady O
    Cancer; 2005 Apr; 103(7):1356-62. PubMed ID: 15717321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder.
    Gibanel R; Ribal MJ; Filella X; Ballesta AM; Molina R; Alcaraz A; Alcover JB
    Anticancer Res; 2002; 22(2B):1157-60. PubMed ID: 12168917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.
    Shariat SF; Matsumoto K; Casella R; Jian W; Lerner SP
    Eur Urol; 2005 Jul; 48(1):69-76. PubMed ID: 15967254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with a negative cystoscopy and negative Nmp22® Bladderchek® test are at low risk of missed transitional cell carcinoma of the bladder: a prospective evaluation.
    Terrell JD; Elias KJ; Sagalowsky AI; Lotan Y
    Int Braz J Urol; 2011; 37(6):706-11. PubMed ID: 22234001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.